DeepMed Research

Universidad de Guanajuato

🇲🇽Mexico

Country: 🇲🇽Mexico

Ownership: Private

Established: 1732-01-01

Employees: -

Market Cap: -

Website: http://www.ugto.mx

Clinical Trials

Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes

Phase 3

Conditions: Prediabetic State
Insulin Resistance

Interventions: Combination Product: Linagliptin + metformin and Empagliflozin + metformin
Drug: Metformin

First Posted Date: 2019-10-18

Last Posted Date: 2019-10-21

Lead Sponsor: Universidad de Guanajuato

Target Recruit Count: 34

Registration Number: NCT04131582

Locations: 🇲🇽
Universidad de Guanajuato, León, Guanajuato, Mexico

Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine

Phase 4

Completed

Conditions: Impaired Glucose Tolerance
Prediabetic State
Insulin Resistance

Interventions: Drug: Linagliptin / Metformin Oral Tablet
Drug: Metformin

First Posted Date: 2019-09-12

Last Posted Date: 2019-09-13

Lead Sponsor: Universidad de Guanajuato

Target Recruit Count: 31

Registration Number: NCT04088461

Locations: 🇲🇽
Universidad de Guanajuato, León, Guanajuato, Mexico

Linagliptin in Post-renal Transplantation

Completed

Conditions: Transplanted Kidney Complication

Interventions: Drug: Insulin
Drug: Linagliptin 5 mg Oral Tablet

First Posted Date: 2019-05-31

Last Posted Date: 2019-06-04

Lead Sponsor: Universidad de Guanajuato

Target Recruit Count: 28

Registration Number: NCT03970668

Mortality Due to Septic Shock Associated With Thrombocytopenia

Conditions: Sepsis Bacterial
Thrombocytopenia
Septic Shock

Interventions: Diagnostic Test: Platelet count

First Posted Date: 2018-08-07

Last Posted Date: 2019-09-25

Lead Sponsor: Universidad de Guanajuato

Target Recruit Count: 350

Registration Number: NCT03617965

Locations: 🇲🇽
Hospital General de León, León, Guanajuato, Mexico

Different Oral Colonization of Gram-negative Bacteria in ICU Patients When Using Chlorhexidine at 0.12% Versus Chlorhexidine at 2.0%

Phase 3

Conditions: Ventilator Associated Pneumonia
Chlorhexidine

Interventions: Drug: Chlorhexidine gluconate at 2%
Drug: Chlorhexidine gluconate at 0.12%

First Posted Date: 2018-02-22

Last Posted Date: 2019-03-11

Lead Sponsor: Universidad de Guanajuato

Target Recruit Count: 74

Registration Number: NCT03442023

Locations: 🇲🇽
University of Guanajuato, Leon, Guanajuato, Mexico

Insulin Schemes for Type 2 Diabetes Control

Phase 4

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: NPH insulin
Drug: Glargine and Lispro insulin

First Posted Date: 2017-11-22

Last Posted Date: 2021-12-06

Lead Sponsor: Universidad de Guanajuato

Target Recruit Count: 75

Registration Number: NCT03350984

Locations: 🇲🇽
Hospital General de León, León, Guanajuato, Mexico

Anthropometric Measures and Anti-inflammatory Markers by a PUFAs Enriched Diet

Not Applicable

Completed

Conditions: Obesity

Interventions: Dietary Supplement: walnuts and almonds

First Posted Date: 2017-07-07

Last Posted Date: 2017-07-07

Lead Sponsor: Universidad de Guanajuato

Target Recruit Count: 40

Registration Number: NCT03211754

Effects of a High-CML Diet on Absorption and Excretion Levels in Healthy Adults

Not Applicable

Completed

Conditions: Healthy

Interventions: Other: Low-CML diet
Other: High-CML diet

First Posted Date: 2017-07-06

Last Posted Date: 2018-06-28

Lead Sponsor: Universidad de Guanajuato

Target Recruit Count: 30

Registration Number: NCT03208946

Locations: 🇲🇽
University of Guanajuato, León, Guanajuato, Mexico

Chlorhexidine Gluconate Solution at 0.125% vs Placebo for the Healing of Grade IIB Ulcers of Diabetic Foot

Phase 4

Conditions: Diabetic Foot

Interventions: Drug: Chlorhexidine gluconate at 0.125%
Drug: Placebo Comparator with physiological saline sterile solution

First Posted Date: 2017-07-06

Last Posted Date: 2019-03-15

Lead Sponsor: Universidad de Guanajuato

Target Recruit Count: 35

Registration Number: NCT03209466

Locations: 🇲🇽
Universidad de Guanajuato, Leon, Guanajuato, Mexico

Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes

Phase 4

Completed

Conditions: Prediabetic State
Insulin Resistance

Interventions: Combination Product: Linagliptin + metformin
Drug: Metformin

First Posted Date: 2016-12-29

Last Posted Date: 2019-07-09

Lead Sponsor: Universidad de Guanajuato

Target Recruit Count: 144

Registration Number: NCT03004612

Locations: 🇲🇽
Universidad de Guanajuato, León, Guanajuato, Mexico

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy